How Jdrf Is Supporting the Development of Closed-loop Systems for Pregnant Women with T1d

JDRF, the leading organization funding type 1 diabetes (T1D) research, is actively supporting the development of closed-loop systems tailored for pregnant women with T1D. These innovative systems aim to improve maternal and fetal health outcomes by providing more precise glucose management during pregnancy.

The Importance of Closed-loop Systems During Pregnancy

Pregnancy presents unique challenges for women with T1D. Hormonal changes can cause unpredictable blood sugar levels, increasing the risk of complications such as preeclampsia, preterm birth, and fetal growth issues. Closed-loop systems, also known as artificial pancreas systems, help automate insulin delivery, maintaining blood glucose within target ranges more consistently.

How JDRF Supports Innovation

JDRF funds research to develop closed-loop systems that are safe and effective for pregnant women. Their support includes grants for engineering new algorithms, improving sensor technology, and clinical trials to test these systems in real-world scenarios. These efforts aim to create systems that adapt to the hormonal fluctuations during pregnancy.

Research and Development Goals

  • Enhance sensor accuracy for rapid changes in glucose levels.
  • Develop algorithms that adjust insulin delivery in real-time during pregnancy.
  • Ensure safety and ease of use for expectant mothers.
  • Conduct clinical trials to validate system performance during pregnancy.

Impact on Maternal and Fetal Health

By supporting these advancements, JDRF aims to reduce the risks associated with T1D during pregnancy. Improved glucose control can lead to healthier pregnancies, fewer complications, and better outcomes for both mother and baby. This progress also offers hope for more autonomous management of T1D in pregnant women in the future.

Conclusion

JDRF’s commitment to developing closed-loop systems specifically for pregnant women with T1D represents a significant step forward in diabetes care. Continued research and innovation promise a future where managing T1D during pregnancy becomes safer, more effective, and less burdensome for women around the world.